TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
AKTS

Aktis Oncology, Inc.

Healthcare · Biotechnology

19.40$ -1.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow AKTS
Line item 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025
-0.08 -0.08 -0.33 -0.68 -0.64 -0.63 -0.84 -0.52 -0.86 0.42 -1.22
0.00 0.00 0.01 0.06 0.09 0.09 0.15 0.01 0.03 0.05 0.04
0.02 0.03 0.23 0.26 0.26 0.20 0.19 0.02 0.04 0.06 0.10
0.00 0.01 0.02 0.04 -0.01 0.03 -0.08 -0.03 0.00 1.69 -0.06
0.01 0.00 0.10 0.34 0.18 0.30 0.51 0.07 0.11 0.08 0.18
-0.01 0.00 -0.27 -0.34 -0.18 -0.29 -0.65 -0.07 -1.97 -5.46 1.26
0.39 0.19 0.92 1.26 1.38 1.35 1.34 3.44 0.93 5.26 -0.02
0.30 0.11 0.32 0.25 0.56 0.42 -0.15 2.86 -2.83 0.22 0.01
-0.09 -0.09 -0.43 -1.01 -0.82 -0.93 -1.35 -0.59 -0.97 0.34 -1.40

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?